--- title: "Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update" type: "News" locale: "en" url: "https://longbridge.com/en/news/286411139.md" description: "Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update." datetime: "2026-05-14T11:32:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286411139.md) - [en](https://longbridge.com/en/news/286411139.md) - [zh-HK](https://longbridge.com/zh-HK/news/286411139.md) --- # Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update. ### Related Stocks - [BFRI.US](https://longbridge.com/en/quote/BFRI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BFRIW.US](https://longbridge.com/en/quote/BFRIW.US.md) ## Related News & Research - [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md) - [](https://longbridge.com/en/news/286807703.md) - [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md) - [Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference](https://longbridge.com/en/news/286652404.md) - [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)